Related references
Note: Only part of the references are listed.Molecular mechanism of proton translocation by cytochrome c oxidase
Ilya Belevich et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes
Gerlincle Wernig et al.
BLOOD (2008)
Up-regulation of WRN and DNA ligase IIIα in chronic myeloid leukernia:: consequences for the repair of DNA double-strand breaks
Annahita Sallmyr et al.
BLOOD (2008)
BCR/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations
Tomasz Stoklosa et al.
CANCER RESEARCH (2008)
BCR/ABL and other kinases from chronic myeloproliferative disorders stimulate single-strand annealing, an unfaithful DNA double-strand break repair
Kimberly Cramer et al.
CANCER RESEARCH (2008)
Evolving concepts on the microenvironmental niche for hematopoietic stem cells
Marc H. G. P. Raaijmakers et al.
CURRENT OPINION IN HEMATOLOGY (2008)
Alternative-NHEJ Is a Mechanistically Distinct Pathway of Mammalian Chromosome Break Repair
Nicole Bennardo et al.
PLOS GENETICS (2008)
The mechanism of human nonhomologous DNA end joining
Michael R. Lieber
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Human CtIP promotes DNA end resection
Alessandro A. Sartori et al.
NATURE (2007)
IgH class switching and translocations use a robust non-classical end-joining pathway
Catherine T. Yan et al.
NATURE (2007)
BCR-tyrosine 177 plays an essential role in Ras and Akt activation and in human hematopoietic progenitor transformation in chronic myelogenous leukemia
Su Chu et al.
CANCER RESEARCH (2007)
Fusion tyrosine kinases: a result and cause of genomic instability
E. T. P. Penserga et al.
ONCOGENE (2007)
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
Brian J. Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance
Mateusz Koptyra et al.
BLOOD (2006)
Activated Jak2 with the V617F point mutation promotes G1/S phase transition
Christoph Walz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML)
C Walz et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
Alternative pathways for the repair of RAG-induced DNA breaks
DM Weinstock et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Chromosomal translocation mechanisms at intronic Alu elements in mammalian cells
B Elliott et al.
MOLECULAR CELL (2005)
A cell-based screening strategy that predicts mutations in oncogenic tyrosine kinases - Implications for clinical resistance in targeted cancer treatment
N von Bubnoff et al.
CELL CYCLE (2005)
Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species
JH Kim et al.
BLOOD (2005)
Human fanconi anemia monoubiquitination pathway promotes homologous DNA repair
K Nakanishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
BCR/ABL translocates to the nucleus and disrupts an ATR-dependent intra-S phase checkpoint
J Dierov et al.
CANCER CELL (2004)
BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks
MO Nowicki et al.
BLOOD (2004)
Genetic steps of mammalian homologous repair with distinct mutagenic consequences
JM Stark et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Targeting mutated tyrosine kinases in the therapy of myeloid leukaemias
L Banerji et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2004)
p210 BCR/ABL kinase regulates nucleotide excision repair (NER) and resistance to UV radiation
Y Canitrot et al.
BLOOD (2003)
Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL
M Azam et al.
CELL (2003)
Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412
E Weisberg et al.
CANCER CELL (2002)
Critical role for Gab2 in transformation by BCR/ABL
M Sattler et al.
CANCER CELL (2002)
Ku DNA end-binding protein modulates homologous repair of double-strand breaks in mammalian cells
AJ Pierce et al.
GENES & DEVELOPMENT (2001)
BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance
A Slupianek et al.
MOLECULAR CELL (2001)
BCR-ABL down-regulates the DNA repair protein DNA-PKcs
E Deutsch et al.
BLOOD (2001)
Chromosomal stability and the DNA double-stranded break connection
DC van Gent et al.
NATURE REVIEWS GENETICS (2001)
The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells
M Sattler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Sister chromatid gene conversion is a prominent double-strand break repair pathway in mammalian cells
RD Johnson et al.
EMBO JOURNAL (2000)
Share Paper
